Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05423366
Other study ID # University of Van YüzüncüYil
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 16, 2022
Est. completion date December 19, 2022

Study information

Verified date January 2023
Source Yuzuncu Yil University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

There is no scientific study in the literature regarding the use of different extracorporeal shock wave therapies (ESWT) in the treatment of patellar tendinopathy. In this study, we aim to investigate both the effectiveness of ESWT and which type of ESWT can be more effective in the treatment of patellar tendinopathy.


Recruitment information / eligibility

Status Completed
Enrollment 75
Est. completion date December 19, 2022
Est. primary completion date November 28, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Engaging in active sports, being 18 years or older, history of activity-related knee pain in the patellar tendon or patellar insertion, symptoms lasting longer than 8 weeks (non-acute), VISA-P score less than 80 before treatment, pain during knee loading on tendon or tendon it remains isolated in the limited part of the bone junction and does not spread to the entire patellar region (to differentiate patellar tendinopathy and patellofemoral pain). Exclusion Criteria: - Being under the age of 18, acute knee or acute patellar tendon injury, chronic inflammatory joint diseases (rheumatoid arthritis, etc.), using immunosuppressive or corticosteroid medication in the last 6 months, previous knee surgery (in the anterior cruciate ligament or patellar tendon), knee in the last 1 month local (corticosteroid) injection, contraindications for ESWT treatment (eg pregnancy, malignancy, coagulopathy), previous ESWT treatment

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Extracorporeal Shock Wave Therapy (ESWT)
The ESWT device is product of Elettronica Pagani, Italy.

Locations

Country Name City State
Turkey Yuzuncu Yil University Van

Sponsors (1)

Lead Sponsor Collaborator
Yuzuncu Yil University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Visual Analogue Scale (VAS) patient's self-assessment of pain, in the range of 0 to 10, higher scores mean a worse at baseline.
Primary Visual Analogue Scale (VAS) patient's self-assessment of pain, in the range of 0 to 10, higher scores mean a worse 3 weeks after baseline.
Primary Visual Analogue Scale (VAS) patient's self-assessment of pain, in the range of 0 to 10, higher scores mean a worse 7 weeks after baseline.
Primary Visual Analogue Scale (VAS) patient's self-assessment of pain, in the range of 0 to 10, higher scores mean a worse 15 weeks after baseline.
Primary Victorian Institute of Sports Assessment-Patella (VISA-P) The Victorian Institute of Sport Assessment-Patella (VISA-P) is a questionnaire to assess the severity of patellar tendinopathies. Theoretically, a maximum score of 100 and a minimum score of 0 can be obtained in the VISA-P questionnaire. Scores below 80 are usually indicative of patellar tendinopathy. at baseline.
Primary Victorian Institute of Sports Assessment-Patella (VISA-P) The Victorian Institute of Sport Assessment-Patella (VISA-P) is a questionnaire to assess the severity of patellar tendinopathies. Theoretically, a maximum score of 100 and a minimum score of 0 can be obtained in the VISA-P questionnaire. Scores below 80 are usually indicative of patellar tendinopathy. 3 weeks after baseline.
Primary Victorian Institute of Sports Assessment-Patella (VISA-P) The Victorian Institute of Sport Assessment-Patella (VISA-P) is a questionnaire to assess the severity of patellar tendinopathies. Theoretically, a maximum score of 100 and a minimum score of 0 can be obtained in the VISA-P questionnaire. Scores below 80 are usually indicative of patellar tendinopathy. 7 weeks after baseline.
Primary Victorian Institute of Sports Assessment-Patella (VISA-P) The Victorian Institute of Sport Assessment-Patella (VISA-P) is a questionnaire to assess the severity of patellar tendinopathies. Theoretically, a maximum score of 100 and a minimum score of 0 can be obtained in the VISA-P questionnaire. Scores below 80 are usually indicative of patellar tendinopathy. 15 weeks after baseline.
See also
  Status Clinical Trial Phase
Completed NCT04153877 - The Effect of Kinesio-tape® on Pain and Vertical Jump Performance in Active Individuals With Patellar Tendinopathy
Completed NCT04339569 - Landing Biomechanics Following Fatigue in Athletes With and Without a History of Patellar Tendinopathy
Completed NCT03694730 - Continued Activity During Rehabilitation in Patients With Patellar Tendinopathy N/A
Completed NCT03528746 - The Acute Effect of Isometric Versus Isotonic Resistance Exercise in Patients With Patellar Tendinopathy N/A
Active, not recruiting NCT04753853 - Stromal Vascular Fraction (SVF) Injection in the Treatment of Patellar Tendinopathy N/A
Completed NCT03917849 - Efficacy of Inertial Flywheel vs Heavy Slow Resistance Training Among Athletes With Patellar Tendinopathy N/A
Active, not recruiting NCT05538494 - Effects on the Patellar Tendon After Low-load Blood Flow Restriction Training. N/A
Completed NCT04219917 - A Comparison of Kinesio® Taping Methods for Subjects With Patellar Tendonitis N/A
Completed NCT04682496 - Ultrasound Probe Pressure on the Intratendon Doppler Signal in Patellar Tendinopathy N/A
Completed NCT03136965 - Platelet-Rich Plasma Therapy for Patellar Tendinopathy Phase 2